by Calcium citrate malate is a calcium supplement that has superior absorption qualities compared to other sources such as calcium carbonate. As a stable compound that readily dissociates in the digestive tract, calcium citrate malate assists optimal calcium balance. Calcium is essential for building strong bones and teeth as well as various metabolic processes in the human body. However, dietary calcium intake is declining in developing nations due to changing eating habits. This has boosted the demand for calcium supplements, especially amongst the aging population.
Calcium citrate malate supplements come in various formulations including tablets, capsules and powders. Being highly bioavailable, calcium citrate malate guarantees nearly 100% calcium absorption compared to other sources. The compound is prescribed by doctors and recommended by nutritionists to strengthen bones, reduce osteoporosis risk and maintain musculoskeletal health. Additionally, calcium citrate malate supplements assist the body in absorbing supplemental calcium along with food intake. The global calcium citrate malate market value stands at US$ 334.08 Mn in 2024.
Market key trends: Rapid urbanization and aging population have led to increasing incidence of bone diseases like osteoporosis globally. This is a major driver for the calcium citrate malate supplements market. Rising health awareness amongst consumers and preference for natural supplements over synthetic alternatives is propelling the demand for calcium citrate malate. Manufacturers are investing in R&D to develop advanced formulations for enhanced bioavailability. New delivery methods like chewable tablets and gummies are gaining popularity due to improved patient compliance. The rising vegan and vegetarian demographic also contributes to the calcium citrate malate market growth as plant-based diets are often low in calcium.
Porter’s Analysis
Threat of new entrants: The threat of new entrants is moderate in the calcium citrate malate market size owing to the availability of new products and technologies. However, presence of established players and requirement of huge capital investments are major barriers for new players.
Bargaining power of buyers: The bargaining power of buyers is high due to availability of alternative products, thus forcing suppliers to offer competitive prices. Buyers can easily switch between suppliers based on price and quality.
Bargaining power of suppliers: The bargaining power of suppliers is high due to limited availability of raw materials and suppliers having an edge over manufacturers. Fluctuations in raw material prices also impacts the overall manufacturing cost.
Threat of new substitutes: Threat of substitutes is low as calcium citrate malate has few direct substitutes and serves as an effective dietary supplement. However, new products may pose a threat if proven to be more effective.
Competitive rivalry: The competitive rivalry is high owing to presence of many regional and international players competing on pricing strategies, product differentiation, and marketing.
Key Takeaways
The global calcium citrate malate market is expected to witness high growth over the forecast period of 2024 to 2031. The global calcium citrate malate market is estimated to be valued at US$ 334.08 Mn in 2024 and is expected to exhibit a CAGR of 8.4% over the forecast period 2024 to 2031.
Regionally, North America dominated the market in 2024 owing to growing health consciousness. Europe is anticipated to be the fastest growing regional market between 2024-2031 supported by increasing product adoption. Growth in the region is driven by rising prevalence of bone disorders and growing geriatric population prone to bone-related diseases. Meanwhile, Asia Pacific is likely to emerge as the fastest growing regional market owing to rising health expenditure and urbanization in China and India.
Key players: Key players operating in the calcium citrate malate market are Omron Corporation, Texas Instruments Incorporated, ABB Limited, TE Connectivity Inc., Sick AG, Omega Engineering Inc., Bosch Sensortec GmbH, Honeywell International Inc., First Sensor AG, Rockwell Automation Inc., NXP Semiconductors NV, Siemens AG, ams AG, and STMicroelectronics Inc. Omron Corporation holds a significant share in pulse oximeter segment.
